Published in J Am Soc Nephrol on June 01, 2005
Predicting Hypotension During Dialysis in the ICU | NCT01171352
Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis. Am J Kidney Dis (2009) 2.06
Hypervolemia is associated with increased mortality among hemodialysis patients. Hypertension (2010) 1.98
Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int (2007) 1.54
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis (2007) 1.32
Assessment and management of hypertension in patients on dialysis. J Am Soc Nephrol (2014) 1.07
Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes. Kidney Int (2009) 0.90
Hypertension in hemodialysis patients: an opinion-based update. Semin Dial (2014) 0.85
Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial. Trials (2012) 0.83
Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations. Pediatr Nephrol (2011) 0.83
Attending rounds: A patient with intradialytic hypotension. Clin J Am Soc Nephrol (2014) 0.83
Whole-body single-frequency bioimpedance analysis in pediatric hemodialysis patients. Pediatr Nephrol (2014) 0.80
Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation. Am J Nephrol (2012) 0.80
A randomized controlled trial of long term effect of BCM guided fluid management in MHD patients (BOCOMO study): rationales and study design. BMC Nephrol (2012) 0.80
Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol (2008) 0.78
Efficacy of hemocontrol biofeedback system in intradialytic hypotension-prone hemodialysis patients. J Korean Med Sci (2014) 0.77
Hemoglobin and hematocrit at the end of hemodialysis: a better way to adjust erythropoietin dose? J Artif Organs (2010) 0.77
Association of bioimpedance spectroscopy-based volume estimation with postdialysis hypotension in patients receiving hemodialysis. Hemodial Int (2015) 0.76
Determinants and short-term reproducibility of relative plasma volume slopes during hemodialysis. Clin J Am Soc Nephrol (2012) 0.76
Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis. Nat Rev Nephrol (2016) 0.76
The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics. Clin J Am Soc Nephrol (2017) 0.75
Fluid First or Not So Fast: Ultrafiltration Rate and the ESRD Quality Incentive Program. Clin J Am Soc Nephrol (2016) 0.75
The Dialysis Sodium Gradient: A Modifiable Risk Factor for Fluid Overload. Nephron Extra (2017) 0.75
Turning the Tide: Improving Fluid Management in Dialysis through Technology. J Am Soc Nephrol (2017) 0.75
Value of bioimpedance analysis estimated "dry weight" in maintenance dialysis patients: a systematic review and meta-analysis. Int Urol Nephrol (2017) 0.75
Alar photoplethysmography: a new methodology for monitoring fluid removal and carotid circulation during hemodialysis. J Clin Monit Comput (2007) 0.75
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med (2015) 13.90
Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA (2009) 13.69
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2015) 10.86
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
The ClinicalTrials.gov results database--update and key issues. N Engl J Med (2011) 9.83
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA (2004) 9.74
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med (2004) 9.13
Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med (2011) 8.54
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ (2002) 6.98
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension (2008) 6.96
Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol (2008) 6.91
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med (2005) 6.86
Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol (2006) 6.86
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10
Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int (2004) 6.04
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation (2008) 5.26
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med (2009) 5.19
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA (2004) 5.11
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (2002) 5.04
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int (2009) 4.72
Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70
What clinicians should know about the QT interval. JAMA (2003) 4.45
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med (2002) 4.42
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Compliance with results reporting at ClinicalTrials.gov. N Engl J Med (2015) 4.17
Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA (2011) 4.09
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA (2011) 3.97
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation (2006) 3.96
Improving patient care. The patient centered medical home. A Systematic Review. Ann Intern Med (2012) 3.90
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med (2005) 3.83
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation (2007) 3.62
Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A (2007) 3.58
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol (2009) 3.54
Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA (2005) 3.51
A multinational cohort study of in-center daily hemodialysis and patient survival. Kidney Int (2012) 3.47
Effect of clinical decision-support systems: a systematic review. Ann Intern Med (2012) 3.42
Benefits of smoking cessation for longevity. Am J Public Health (2002) 3.38
Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol (2008) 3.35
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int (2008) 3.34
Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol (2009) 3.30
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA (2002) 3.24
Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer (2002) 3.05
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med (2002) 3.01
Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA (2002) 2.98
The role of academic health science systems in the transformation of medicine. Lancet (2009) 2.98
Peer-reviewed publication of clinical trials completed for pediatric exclusivity. JAMA (2006) 2.92
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. JAMA Intern Med (2013) 2.86
Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int (2004) 2.81
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail (2008) 2.69
Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Med (2004) 2.64
Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol (2011) 2.62
Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry (2003) 2.60
Lessons learned from recent cardiovascular clinical trials: Part I. Circulation (2002) 2.57
Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol (2006) 2.56
Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int (2004) 2.52
Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis (2012) 2.51
Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care (2010) 2.51
Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med (2009) 2.49
International differences in evolution of early discharge after acute myocardial infarction. Lancet (2004) 2.47
Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial. J Am Coll Cardiol (2007) 2.47
A systematic review of diabetes disease management programs. Am J Manag Care (2005) 2.46
Randomized clinical trials--removing unnecessary obstacles. N Engl J Med (2013) 2.43
Donor kidney exchanges. Am J Transplant (2004) 2.39
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail (2007) 2.39